Li Bian
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 37
- HER2/EGFR in Cancer Research 20
- Cancer Cells and Metastasis 4
- Cancer Immunotherapy and Biomarkers 4
-
- Breast Cancer Treatment Studies 8
- Cancer Genomics and Diagnostics 5
- Co-authors
- Ze-Fei Jiang (30 shared papers)Shaohua Zhang (26 shared papers)Xiao‐Jing Wang (12 shared papers)Gangwen Han (7 shared papers)Yongwen He (7 shared papers)Yi Liu (6 shared papers)Christian D. Young (9 shared papers)Fulun Li (4 shared papers)
- Journals
- Annals of Translational Medicine (3 papers)Journal of Investigative Dermatology (3 papers)BMC Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Li Bian
65 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 77
- Oncology 407
- Cancer Research 188
- Otorhinolaryngology 36
- Pulmonary and Respiratory Medicine 171
- Genetics 43
Countries citing papers authored by Li Bian
This map shows the geographic impact of Li Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Bian more than expected).
Fields of papers citing papers by Li Bian
This network shows the impact of papers produced by Li Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Bian. The network helps show where Li Bian may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Bian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 119 | |
| 2 | 2020 | 87 | |
| 3 | 2013 | 81 | |
| 4 | 2013 | 74 | |
| 5 | 2013 | 63 | |
| 6 | 2017 | 44 | |
| 7 | 2015 | 42 | |
| 8 | In vitro and in vivo immunosuppressive characteristics of hepatocyte growth factor-modified murine mesenchymal stem cells. | 2009 | 38 |
| 9 | 2016 | 30 | |
| 10 | 2018 | 29 | |
| 11 | 2021 | 29 | |
| 12 | 2019 | 27 | |
| 13 | 2020 | 27 | |
| 14 | 2015 | 21 | |
| 15 | 2021 | 20 | |
| 16 | 2013 | 19 | |
| 17 | 2019 | 19 | |
| 18 | 2014 | 18 | |
| 19 | 2020 | 18 | |
| 20 | 2018 | 16 |
About Li Bian
Li Bian is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Immunology, having authored 69 papers that have together received 1.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (20 papers), Breast Cancer Treatment Studies (8 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Cells and Metastasis (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Oral health in cancer treatment (4 papers), Cell death mechanisms and regulation (4 papers) and TGF-β signaling in diseases (3 papers). The work is most often cited by research in Oncology (407 citations), Cancer Research (188 citations), Otorhinolaryngology (36 citations), Pulmonary and Respiratory Medicine (171 citations) and Genetics (43 citations). Li Bian has collaborated with scholars based in China, United States and France. Frequent co-authors include Ze-Fei Jiang, Shaohua Zhang, Xiao‐Jing Wang, Gangwen Han, Yongwen He, Yi Liu, Christian D. Young, Fulun Li, Haixu Hu and Bing Liu. Their work appears in journals such as Annals of Translational Medicine, Journal of Investigative Dermatology, BMC Cancer, International Journal of Radiation Oncology*Biology*Physics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.